Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055

Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain

DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439

Neuropathological Classification of Huntingtonʼs Disease

VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227

Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation

Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,188

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the “phosphocreatine circuit” for cellular energy homeostasis

Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011

Spatial Localization in NMR Spectroscopy in Vivo

Bottomley, P. A. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb32915.x · Cited by 1,382

Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology

Gutekunst, C.-A., Li, S.-H., Yi, H., Mulroy, J. S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R. J., Hersch, S. M., & Li, X.-J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02522.1999 · Cited by 914

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Ferro, A., Carbone, E. A., Marzouk, E., Siegel, A., Nguyen, D., Polley, K., Hartman, J., Frederick, K. A., Ives, S. J., & Lagalwar, S. (2017) · Journal of Visualized Experiments · doi:10.3791/53758 · Cited by 6

Creatine: prescription for bad genes and a hostile environment?

Mattson, M. P. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01697-0 · Cited by 6

Effect of creatine supplementation on cognitive performance and apoptosis in a rat model of amyloid-beta-induced Alzheimer's disease.

Alimohammadi‐Kamalabadi, M., Eshraghian, M., Zarindast, M., Aliaghaei, A., & Pishva, H. (2016) · PubMed Central · doi:10.22038/ijbms.2016.7814 · Cited by 5

Modern approaches for modelling dystonia and Huntington's disease in vitro and in vivo

Zhunina, O. A., Yabbarov, N. G., Orekhov, A. N., & Deykin, A. V. (2019) · International Journal of Experimental Pathology · doi:10.1111/iep.12320 · Cited by 6

Plans for HDBase—a research community website for Huntington's Disease

Goodman, N., McCormick, K. M., Goldowitz, D., Hockly, E., Johnson, C., Kristal, B. S., MacDonald, M. E., Truant, R., & van Beuzekom, M. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00062-8 · Cited by 5

Resistência à insulina com a suplementação de creatina em animais de experimentação

Costallat, B. L., Miglioli, L., Silva, P. A. C., Novo, N. F., & Duarte, J. L. G. (2007) · Revista Brasileira de Medicina do Esporte · doi:10.1590/s1517-86922007000100006 · Cited by 5

Psychology of Supplementation in Sport and Exercise: Motivational Antecedents and Biobehavioral Outcomes

Lutz, R. S., & Arent, S. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-231-1_2 · Cited by 5

Molecular Imaging of Gene Therapy for Neurogenetic Diseases

Wolfe, J. H. N., Acton, P. D., Poptani, H., & Vite, C. H. (2006) · Elsevier eBooks · doi:10.1016/b978-012397632-1/50026-5 · Cited by 5

Huntington Disease

Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50018-8 · Cited by 5

Concentrations of creatine, creatinine, carnosine, and anserine in bovine longissimus muscle and their correlations with carcass and palatability traits

Liu, Q. (2011) · doi:10.31274/etd-180810-682 · Cited by 5

Clinical and Research Advances in Huntington's Disease

SuttonBrown, M., & Suchowersky, O. (2003) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003231 · Cited by 5

Creatine Monohydrate

Singh, S., & Dash, A. K. (2009) · Profiles of drug substances, excipients, and related methodology · doi:10.1016/s1871-5125(09)34001-7 · Cited by 4

Neuroprotective effect of creatine against propionic acid toxicity in neuroblastoma SH-SY5Y cells in culture

Afaf, E. A., Ghada, A. S., & Abeer, A. D. (2013) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb12.2880 · Cited by 4

Disease-Modification in Huntington’s Disease: Moving Away from a Single-Target Approach

Jensen, M. P., & Barker, R. A. (2019) · Journal of Huntington s Disease · doi:10.3233/jhd-180320 · Cited by 4

1H NMR-Based Metabolic Profiling of Urine from Mice Fed Lentinula edodes-Derived Polysaccharides

Xu, X., Yang, J., Ning, Z., & Zhang, X. (2018) · Polish Journal of Food and Nutrition Sciences · doi:10.1515/pjfns-2017-0029 · Cited by 4

Huntington Disease

McGarry, A. J., Biglan, K., & Marshall, F. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00075-9 · Cited by 4

Identifying Factors of Microparticles Modified with Arginine Derivatives That Induce Phenotypic Shifts in Macrophages

Dunn-Sale, A. J., & Bratlie, K. M. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00041 · Cited by 4

Physiological Basis for Creatine Supplementation in Skeletal Muscle

Kraemer, W., Luk, H.-Y., Lombard, J. R., Dunn-Lewis, C., & Volek, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396454-0.00039-4 · Cited by 5

Translating therapies for Huntington’s disease from genetic animal models to clinical trials

Hersch, S. M., & Ferrante, R. J. (2004) · Neurotherapeutics · doi:10.1007/bf03206614 · Cited by 4

Magnetic resonance imaging in Huntington's disease

Belogianni, C., Wilson, H., de Natale, E. R., & Politis, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821651-4.00001-4 · Cited by 4

Epilepsy expands the phenotype of L‐arginine:glycine amidinotransferase deficiency

Ferretti, A., Battini, R., Gagliardo, O., Verrigni, D., Manca, M. B., Ferrari, A. R., Salerno, G., Boccia, R., Polese, D., Cocco, C., et al. (2025) · Epilepsia · doi:10.1111/epi.18565 · Cited by 3

Combination Supplement Therapy: A New Frontier in Treatment of Neurodegenerative Diseases

Shtilbans, A. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.07.004 · Cited by 3

HUNTINGTON'S DISEASE AND OTHER CHOREAS

Shannon, K. M. (2004) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293569.94833.a3 · Cited by 3

Transplants of CNTF-producing Cells for the Treatment of Huntington's Disease

Escartin, C., Hantraye, P., & Déglon, N. (2007) · Elsevier eBooks · doi:10.1016/b978-012369415-7/50023-5 · Cited by 3

Effect of Sodium Butyrate on Working Memory and Serum Level Expression of Neural Growth Factor in an Animal Model of Prenatal Stress

Akrami, F., & Edalatmanesh, M. A. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.3.9 · Cited by 3

High serum creatinine is associated with reduction of psychiatric symptoms in female patients with anti-NMDAR encephalitis

Wang, N., Zeng, Z., Wang, B., Qin, D., Wang, T., Wang, C., & Guo, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135650 · Cited by 3

Biotechnology

Ma, Q. (2021) · Advances in human and social aspects of technology book series · doi:10.4018/978-1-7998-6772-2.ch007 · Cited by 3

Harnessing the Power of Osmolytes for Industrial and Pharmaceutical Applications

Giri, S., Singh, P., Biswas, M., Mishra, R., & Poddar, N. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-6001-5_8 · Cited by 3

Espectroscopia cuantitativa de hidrógeno por resonancia magnética de 3 T en pacientes sintomáticos y asintomáticos con enfermedad de Huntington

Alcauter, S., Pasaye, E. H., Alvarado-Alanis, P., Delgado, R. O. F., Vilatela, M. E. A., Lujambio, P. S., & Barrios, F. A. (2010) · Revista de Neurología · doi:10.33588/rn.5104.2009173 · Cited by 3

Early Dysfunction of Neural Transmission and Cognitive Processing in Huntington’s Disease

Michael, I., Steffes-Lovdahl, S. K., Jayaprakash, N., Wolfram-Aduan, A., & Gary, L. (2012) · InTech eBooks · doi:10.5772/30528 · Cited by 3

Energy Metabolism in Huntington’s Disease

Fabola, M., Dobránsky, T., Gervsio-Carvalho, E. A. D., Jader, S., & Fernando, A. (2012) · InTech eBooks · doi:10.5772/31610 · Cited by 3

Huntington's disease

Kosinski, C. M., & Landwehrmeyer, G. B. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.058 · Cited by 3

Physiological Basis for Creatine Supplementation in Skeletal Muscle and the Central Nervous System

Kraemer, W. J., Beeler, M. K., Post, E. M., Luk, H., Lombard, J. R., Dunn‐Lewis, C., & Volek, J. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813922-6.00049-7 · Cited by 3

HUNTINGTON DISEASE: CURRENT ADVANCES IN PATHOGENESIS AND RECENT THERAPEUTIC STRATEGIES

Wani, T. A., Al-Omara, M. A., & Zargar, S. (2011) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2011.030201 · Cited by 3

Chapter 5 Mitochondrial Abnormalities in Neurodegenerative Disorders

Tabrizi, S. J., & Schapira, A. H. V. (2002) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70064-9 · Cited by 3

Therapeutic Prospects for Polyglutamine Disease

Pennuto, M., & Fischbeck, K. H. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch40 · Cited by 3

3-Nitropropionic acid induces histological and behavioral alterations in adult zebrafish: role of antioxidants on behavioral dysfunctionPreprint

Wiprich, M. T., Vasques, R. D. R., Zaluski, A. B., Bertoncello, K. T., Altenhofen, S., Gusso, D., Rodrigues, G., Sachett, A., Piato, Â., Maito, F. L. D. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.29.591507 · Cited by 3

Potential Therapeutic Strategies for Neurodegenerative Diseases

Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0_9 · Cited by 2

Manganese and Huntington Disease

Tidball, A. M., Bichell, T. J., & Bowman, A. B. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622383-00540 · Cited by 2

The Psychology of Supplementation in Sport and Exercise: Motivational Antecedents and Biobehavioral Outcomes

Arent, S. M., & Lutz, R. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-18230-8_2 · Cited by 2

Dopamine and Glutamate in Huntington’s Disease

Cepeda, C., Ariano, M. A., & Levine, M. S. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_23 · Cited by 3

Huntington disease

Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00014-7 · Cited by 2

Mechanistic Insights into the Polyglutamine Ataxias

Miller, V. M., & Paulson, H. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_23 · Cited by 2

Therapeutics in Huntington’s Disease

Rosas, H. D., & Koroshetz, W. J. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_17 · Cited by 2

Morbus Huntington – a human genetic model disease

Epplen, J. T., Genčík, M., Epplen, A. S. C., Andrich, J., Carsten Saft, C., & Przuntek, H. (2000) · Cytogenetic and Genome Research · doi:10.1159/000056825 · Cited by 2

Enfermedad de Huntington: estado del arte

Sepúlveda, C. D. R., & García, N. S. (2014) · Repository Technological University of Pereira (Technological University of Pereira) · Cited by 2

Creatine Effects on Kidney Tissues and Renal Function: New Insights from a Bioinformatic StudyPreprint

Medeiros, M. A., Abreu, B. J., & Lima, J. P. M. S. (2024) · Preprints.org · doi:10.20944/preprints202406.1733.v1 · Cited by 1

Clinical Features and Care

Shoulson, I. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00025-8 · Cited by 2

Creatine lysinate – part II: effects on the motor coordination and muscle hypertrophy in mice

Kostadinova, I., Danchev, N. D., Landzhov, B. V., Tsvetkova, D. D., Marinov, L., & Ivanova, I. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e110718 · Cited by 1

Molecular Pathogenesis and Therapeutic Targets in Huntington's Disease

Bett, J. S., Bates, G. P., & Hockly, E. (2006) · Elsevier eBooks · doi:10.1016/b978-012369462-1/50015-6 · Cited by 1

Validation of Dementia Models Employing Neuroimaging Techniques

Vanhoutte, G., Campo, A., & der Linden, A. V. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_11 · Cited by 1

Huntington disease

Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00013-5 · Cited by 1

Huntington Disease and Other Choreas

Videnović, A., & Shannon, K. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-60327-120-2_2 · Cited by 2

The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex® - A Cannabis-derived Spray

Motamedy, S., Soltani, B., Kameshki, H., Kermani, A. A., Amleshi, R. S., Nazeri, M., & Shabani, M. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575285934240123110158 · Cited by 1

Biotechnology

Ma, Q. (2023) · IGI Global eBooks · doi:10.4018/979-8-3693-3026-5.ch016 · Cited by 1

Creatine supplementation and exercise as possible therapeutic treatments in Parkinson’s Disease: A review

Graham, S. M., Baird, M., & Boyd, G. W. (2014) · Archives of Exercise in Health and Disease · doi:10.5628/aehd.v4i3.169 · Cited by 1

Efeitos da suplementação com CrH2O sobre a quimioluminescência urinária em universitários submetidos a 8 semanas de treinamento de força

de Souza, T. P., Dubas, J. P., Pereira, B., & de Oliveira, P. R. (2007) · Conexões · doi:10.20396/conex.v3i2.8637955 · Cited by 1

Magnetic resonance spectroscopy of neurodegenerative illness

Jenkins, B. G., Choi, J., & Beal, M. F. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.022 · Cited by 1

Mouse Models of Triplet Repeat Diseases

Bates, G. P., & Hay, D. (2004) · Humana Press eBooks · doi:10.1385/1-59259-804-8:003 · Cited by 1

Identifying new therapeutics for Huntington's disease

Schilling, G., & Borchelt, D. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00060-4 · Cited by 1

A Gain of Function of the Huntington’s Disease and Amyotrophic Lateral Sclerosis-Associated Genetic Mutations May Be a Loss of Bioenergetics

Beal, M. F. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_13 · Cited by 1

Ensaio clínico randomizado, duplo-cego, controlado com placebo, de monoidrato de creatina como terapia adjuvante na depressão bipolar

Toniolo, R. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-07122016-150647 · Cited by 1

Clinical Applications

Weir, J. P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-573-2_6 · Cited by 1

Modulation of the JAK2/STAT3 pathway in vivo : understanding reactive astrocyte functional features and contribution to neurodegenerative diseases

Haim, L. B. (2014) · theses.fr (ABES) · doi:10.70675/75a69111z994cz43dfzb795zfeae9ffc88ab · Cited by 1

Mitochondrial Membrane Permeabilization in Physiological and Pathological Cell Death

Ravagnan, L., & Kroemer, G. (2001) · Research and perspectives in neurosciences · doi:10.1007/978-3-662-04333-2_2

Influencia da suplementação de creatina na modulação da captação de glicose em ratos sumetidos ou não a atividade fisica

Freire, T. O. (2006) · doi:10.47749/t/unicamp.2006.373594

The molecular pathogenesis of Huntington’s disease

Turner, C. D. (2009) · UCL Discovery (University College London)

Intrabodies as Therapeutics for Huntington’s Disease

Southwell, A. L. (2009) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/ddsd-7k09

The Study of Two Strategies for Decreasing Mutant Huntingtin: Degradation by Puromycin Sensitive AminoPeptidase and RNA Interference: A Dissertation

Chaurette, J. (2013) · doi:10.13028/m2930z

THE ROLE OF P53 IN OXIDATIVE STRESS AND POLYGLUTAMINE NEUROTOXICITY

Dunn, J. C. (2003) · UKnowledge (University of Kentucky)

Degenerative Risks for Parkinson's Disease After Toxin Exposure and Stress

Ariano, M. A. (2000) · doi:10.21236/ada383079

Definiendo la etiopatogénesis del síndrome de deficiencia de creatina cerebral

Alonso, P. A. (2014) · Biblos-e Archivo (Universidad Autónoma de Madrid)

The Cross-Talk Between Mitochondria and the Nucleus in the Response to Oxidative Stress Associated with Mitochondrial Dysfunction in Mitochondrial Encephalomyopathies

Wu, Y., Lee, W., Wu, S., & Wei, Y. (2011) · InTech eBooks · doi:10.5772/19713

Avaliação de pacientes com esclerose mesial temporal pela espectroscopia de fósforo por ressonância magnética em aparelho 3T

Park, E. J. (2013) · doi:10.11606/t.5.2013.tde-08082013-093201

Creatine as a neuroprotective agent in manganese-induced neurotoxicity

Farah, S. I. (2011) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)

Eficácia e segurança da suplementação de creatina acompanhada de treinamento físico em diabéticos tipo 2: estudo clínico, randomizado, duplo-cego, controlado por placebo

Gualano, B. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.39.2010.tde-22042010-093413

Sports Applications of Creatine

Kreider, R. B. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-302-8_20

Diagnóstico bioquímico das síndromes de deficiência de creatina

Madeira, M. D. F. (2010) · doi:10.11606/t.5.2010.tde-22062010-133327

Efeitos da suplementação de creatina sobre a função renal de praticantes de treinamento de força: um estudo randomizado, duplo-cego, controlado por placebo

Lugaresi, R. (2013) · doi:10.11606/d.39.2013.tde-08102013-133955

Disorders of the mitochondrial respiratory chain

Schapira, A. H. V. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.063

OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION IN TRAUMATIC BRAIN INJURY IN AGING

Shao, C. (2007) · UKnowledge (University of Kentucky)

Creatine and Ginkgo Biloba Use in Sports and Health: A Knowledge Utilization Approach

Geiger, J. D., Legace-Wiens, P., Bastianetto, S., & Quirion, R. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1067-3_9

β-cell dysfunction in Huntington's disease

Bacos, K. (2009) · Lund University Publications (Lund University)

Alterations of Thalamostriatal and Corticostriatal Projections in Mouse Models of Huntington’s Disease

Parievsky, A. (2015) · eScholarship (California Digital Library)

Eleventh meeting of The European Neurological Society21–25 April, 2001, Paris, France

Berciano, J., Bogousslavsky, J., Boon, P., Comi, G. P., Członkowska, A., Compston, D. A. S., Diener, H., DiDonato, S., Hildebrand, J. G., Hohlfeld, R., et al. (2001) · Journal of Neurology · doi:10.1007/bf03160438

Effect of creatine monohydrate supplementation for 3 weeks on testosterone conversion to dihydrotestosterone in young rugby players

van der Merwe, J. (2006) · SUNScholar (Stellenbosch University)

Molecular Pathways of Mitochondrial Dysfunction in Neurodegeneration: the Paradigms of Parkinson's and Huntington's Diseases

Rego, A. C., Cardoso, S. M., & Oliveira, C. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_9 · Cited by 1

Bioenergetic Defects and Oxidative Damage in Transgenic Mouse Models of Neurodegenerative Disorders

Browne, S. E. (2003) · Defense Technical Information Center (DTIC) · doi:10.21236/ada419306

Murine Models of Huntington Disease

Sturrock, A., & Leavitt, B. R. (2009) · Future Neurology · doi:10.2217/fnl.09.34

Altered Affect, Monoamine Transmitters and Bioenergetic Homeostasis of Alpha-Synuclein-Transgenic Mice, in the Presence and Absence of Endogenous Alpha-Synuclein

Cumyn, E. M. (2010) · TSpace (University of Toronto)

Running head: Creatine feeding increases muscle GLUT4

Ju, J.-S., Smith, J. L., Oppelt, P., & Fisher, J. S. (2004)

Efeitos da hiperfenilalaninemia materna em ratas Wistar sobre alguns parâmetros de metabolismo energético na prole e efeito protetor da associação de piruvato com creatina

Bortoluzzi, V. T. (2014) · Americanae (AECID Library)

Mechanismen von Exzitotoxizität und Neuroprotektion in hippocampalen Zellen in einem in vitro Modell der Schizophrenie

Möller, H. (2009)

Huntington's Disease: Unraveling the Pathophysiological Cascade Behind a Singular Gene Defect

Kosinski, C. M., Landwehrmeyer, G. B., & Ludolph, A. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_11

Role of Mitochondria in Parkinson’s Disease and Huntington’s Disease

Schapira, A. H. V. (2012) · Oxidative stress and disease · doi:10.1201/b12308-23

Oxidative Stress and Huntington’s Disease

Turner, C., & Schapira, A. H. V. (2003) · Oxidative stress and disease · doi:10.1201/9780203912874.ch20

creatine monohydrate supplementation in skeletal muscle of young men following short-term Global and targeted gene expression and protein content

Safdar, A., Yardley, N. J., Snow, R. J., & Melov, S. (2016)

Huntington’s Disease

Raymond, L. A., & Leavitt, B. R. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch16

Cyclosporin A Protects Striatal Neurons from Mitochondrial Dysfunction: Implications for Huntington's Disease

Leventhal, L., & Kordower, J. H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-315-1:159

Degenerative Movement Disorders of the Central Nervous System

Doherty, J., Fried, G. W., & Saulino, M. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0884-4.10051-5

Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice

Dedeoglu, A., Kubilus, J. K., Yang, L., Ferrante, K. L., Hersch, S. M., Beal, M. F., & Ferrante, A. R. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01706.x · Cited by 169

Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease

Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., Jenkins, B. G., Ferrante, K. L., Thomas, M., Friedlich, A., Browne, S. E., Schilling, G., Borchelt, D. R., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0406 · Cited by 293

Creatine: prescription for bad genes and a hostile environment?

Mattson, M. P. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01697-0 · Cited by 6

Neuroprotective effects of creatine

Beal, M. F. (2011) · Amino Acids · doi:10.1007/s00726-011-0851-0 · Cited by 196

Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease

Matthews, R. T., Yang, L., Jenkins, B. G., Ferrante, R. J., Rosen, B. R., Kaddurah-Daouk, R. F., & Beal, M. F. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00156.1998 · Cited by 431